Interventional technology firm Medtronic has received regulatory approval from the government of the People's Republic of China for its Endeavor drug-eluting coronary stent system.
Endeavor is now commercially available in approximately 100 countries, according to the Minneapolis-based firm. Medtronic said it remains on track to complete the premarket approval (PMA) process for Endeavor in the U.S. in 2007.
By AuntMinnie.com staff writers
June 21, 2006
Related Reading
Medtronic nets French reimbursement approval, June 12, 2006
Stereotaxis, Medtronic partner for clinical study, May 18, 2006
Medtronic gets nod for Micro-Driver, May 1, 2006
Medtronic sues Kyphon, April 17, 2006
Medtronic gets FDA nod for AAA stent system, March 28, 2006
Copyright © 2006 AuntMinnie.com
